DIN 02252716 — CIPRODEX 0.3 %; 0.1 %
CIPRODEX is a suspension of Ciprofloxacin / Dexamethasone marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Ciprofloxacin / Dexamethasone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02252716
- Brand name
- CIPRODEX
- Active ingredient
- Ciprofloxacin / Dexamethasone
- Strength
- 0.3 %; 0.1 %
- Dosage form
- SUSPENSION
- Route
- OTIC
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Fluoroquinolone antibiotic / corticosteroid combination (otic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ciprofloxacin / Dexamethasone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02506882 | SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 0.3 %; 0.1 % | SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02481901 | TARO-CIPROFLOXACIN/DEXAMETHASONE | 0.1 %; 0.3 % | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |